4 results

  • ketorolac tromethamine

    (ketorolac tromethamine)
    Almaject, Inc.
    Ketorolac tromethamine is indicated for short-term management (≤5 days) of moderately severe acute pain requiring opioid-level analgesia, typically in postoperative settings. It should be initiated via IV or IM, with oral use as continuation. Total use must not exceed 5 days due to potential adverse reactions.

  • labetalol hydrochloride

    (labetalol hydrochloride)
    Almaject, Inc.
    Labetalol hydrochloride injection is indicated for the control of blood pressure in severe hypertension.

  • regadenoson

    (Regadenoson)
    Almaject, Inc.
    Regadenoson injection is indicated as a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients who are unable to perform adequate exercise stress testing.

  • temsirolimus

    (Temsirolimus Injection)
    Almaject, Inc.
    Temsirolimus injection is indicated for the treatment of advanced renal cell carcinoma.